Insomnia Perplexes Sleep Experts

AUGUST 01, 2005

Chronic insomnia remains a mystery, concluded a panel of specialists convened by the National Institutes of Health. The panel did find, however, that chronic insomnia is a major health problem, and too many individuals are using unproven therapies, even with treatments available that are effective. The panel's report, "Manifestations and Management of Chronic Insomnia in Adults" found:

  • Cognitive/behavioral therapy is effective and does not have side effects
  • New prescription sleep pills work without many of the side effects associated with older agents known as benzodiazepines
  • The most commonly used treatments are alcohol and OTC sedating antihistamines; alcohol usually disrupts quality sleep, and antihistamines can cause lasting daytime sedation and other cognitive problems
  • There is no evidence supporting the effectiveness of the dietary supplements melatonin and valerian to combat insomnia

The panel recommended a broader range of research into insomnia, reporting that, if researchers understood its underlying cause, they could develop effective treatments.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.